Cannabinoid pharmacology

Research output: Contribution to journalArticle

321 Citations (Scopus)

Abstract

Research into the pharmacology of individual cannabinoids that began in the 1940s, several decades after the presence of a cannabinoid was first detected in cannabis, is concisely reviewed. Also described is how this pharmacological research led to the discovery of cannabinoid CB1 and CB2 receptors and of endogenous ligands for these receptors, to the development of CB1- and CB2-selective agonists and antagonists and to the realization that the endogenous cannabinoid system has significant roles in both health and disease, and that drugs Which mimic, augment or block the actions of endogenously released cannabinoids must have important therapeutic applications. Some goals for future research are identified.

Original languageEnglish
Pages (from-to)S163-S171
Number of pages9
JournalBritish Journal of Pharmacology
Volume147
Issue numberS1
DOIs
Publication statusPublished - Jan 2006

Keywords

  • cannabis
  • cannabinoids
  • endocannabinoids
  • cannabinoid receptor agonists
  • cannabinoid receptor antagonists
  • anandamide
  • 2-arachidonoyl glycerol
  • autoprotection
  • autoimpairment
  • RECEPTOR
  • ANANDAMIDE
  • METABOLISM
  • MECHANISMS
  • POTENT
  • CB1
  • cannabis
  • cannabinoids
  • endocannabinoids
  • cannabinoid receptor agonists
  • cannabinoid receptor antagonists
  • anandamide
  • 2-arachidonoyl glycerol
  • autoprotection

Cite this

Cannabinoid pharmacology. / Pertwee, Roger Guy.

In: British Journal of Pharmacology, Vol. 147, No. S1, 01.2006, p. S163-S171.

Research output: Contribution to journalArticle

Pertwee, Roger Guy. / Cannabinoid pharmacology. In: British Journal of Pharmacology. 2006 ; Vol. 147, No. S1. pp. S163-S171.
@article{e18e180a572f432b8afac34d9cabd126,
title = "Cannabinoid pharmacology",
abstract = "Research into the pharmacology of individual cannabinoids that began in the 1940s, several decades after the presence of a cannabinoid was first detected in cannabis, is concisely reviewed. Also described is how this pharmacological research led to the discovery of cannabinoid CB1 and CB2 receptors and of endogenous ligands for these receptors, to the development of CB1- and CB2-selective agonists and antagonists and to the realization that the endogenous cannabinoid system has significant roles in both health and disease, and that drugs Which mimic, augment or block the actions of endogenously released cannabinoids must have important therapeutic applications. Some goals for future research are identified.",
keywords = "cannabis, cannabinoids, endocannabinoids, cannabinoid receptor agonists, cannabinoid receptor antagonists, anandamide, 2-arachidonoyl glycerol, autoprotection, autoimpairment, RECEPTOR, ANANDAMIDE, METABOLISM, MECHANISMS, POTENT, CB1, cannabis , cannabinoids , endocannabinoids , cannabinoid receptor agonists , cannabinoid receptor antagonists , anandamide , 2-arachidonoyl glycerol , autoprotection",
author = "Pertwee, {Roger Guy}",
year = "2006",
month = "1",
doi = "10.1038/sj.bjp.0706406",
language = "English",
volume = "147",
pages = "S163--S171",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "S1",

}

TY - JOUR

T1 - Cannabinoid pharmacology

AU - Pertwee, Roger Guy

PY - 2006/1

Y1 - 2006/1

N2 - Research into the pharmacology of individual cannabinoids that began in the 1940s, several decades after the presence of a cannabinoid was first detected in cannabis, is concisely reviewed. Also described is how this pharmacological research led to the discovery of cannabinoid CB1 and CB2 receptors and of endogenous ligands for these receptors, to the development of CB1- and CB2-selective agonists and antagonists and to the realization that the endogenous cannabinoid system has significant roles in both health and disease, and that drugs Which mimic, augment or block the actions of endogenously released cannabinoids must have important therapeutic applications. Some goals for future research are identified.

AB - Research into the pharmacology of individual cannabinoids that began in the 1940s, several decades after the presence of a cannabinoid was first detected in cannabis, is concisely reviewed. Also described is how this pharmacological research led to the discovery of cannabinoid CB1 and CB2 receptors and of endogenous ligands for these receptors, to the development of CB1- and CB2-selective agonists and antagonists and to the realization that the endogenous cannabinoid system has significant roles in both health and disease, and that drugs Which mimic, augment or block the actions of endogenously released cannabinoids must have important therapeutic applications. Some goals for future research are identified.

KW - cannabis

KW - cannabinoids

KW - endocannabinoids

KW - cannabinoid receptor agonists

KW - cannabinoid receptor antagonists

KW - anandamide

KW - 2-arachidonoyl glycerol

KW - autoprotection

KW - autoimpairment

KW - RECEPTOR

KW - ANANDAMIDE

KW - METABOLISM

KW - MECHANISMS

KW - POTENT

KW - CB1

KW - cannabis

KW - cannabinoids

KW - endocannabinoids

KW - cannabinoid receptor agonists

KW - cannabinoid receptor antagonists

KW - anandamide

KW - 2-arachidonoyl glycerol

KW - autoprotection

U2 - 10.1038/sj.bjp.0706406

DO - 10.1038/sj.bjp.0706406

M3 - Article

VL - 147

SP - S163-S171

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - S1

ER -